Abstract:Objective: The traditional Chinese medicine Anluohuaxianwan (ALHXW) has been used to treat liver fibrosis induced by chronic hepatitis B virus (HBV) infection. However, the anti-fibrosis mechanisms of ALHXW remain to be investigated. This study used a rat model of carbon tetrachloride (CCl(4))-induced liver fibrosis to explore the potential antifibrogenic mechanisms of ALHXW. Methods: Twenty-seven male Wistar rats were randomly assigned to control group, model group, and treatment group (n = 9 per group). Rats in the model and treatment group were injected intraperitoneally with 40% CCl(4)(2 ml/kg), and rats in the control group were administered saline twice a week for 6 weeks. Starting at week 4 following model construction, rats in the treatment group received daily gavages with ALHXW solution (concentration 0.15 g/ml) daily, while rats in the control and model groups were given saline for a total of 6 weeks. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured from blood samples collected at the end of weeks 3, 6 and 9. Histopathological examination of liver tissue was performed to evaluate liver fibrosis at week 9. At the same time, the mRNA expression of TGF-β1 and Smads in liver tissues was quantified by real-time reverse transcription polymerase chain reaction (RT-PCR), and TGF-β1 protein level in the liver was measured by Western blot. Inter-group comparison was performed using analysis of variance (ANOVA) when the continuous data were normally distributed and satisfied the homogeneity of variance; otherwise, nonparametric tests were used. Categorical data were compared between groups using nonparametric tests. Results: ALHXW markedly alleviated liver injury in the treatment group after 3 weeks of therapy as indicated by a significantly reduced level of ALT compared with the model group [(162.98 ± 73.14)U/L vs (322.52 ± 131.76)U/L, P = 0.047], and a 39.8% reduction in AST level compared with the model group[ (537.56 ± 306.06)U/L vs (892.98 ± 358.19)U/L, P = 0.053]. Moreover, at the end of the 6-week therapy, histopathological diagnosis showed that liver fibrosis was significantly reduced in the ALHXW-treated group compared with that in the model group (P = 0.002). The relative expression of TGF-β1 mRNA and protein in the liver were significantly lower in ALHXW-treated rats than that in model rats (1.34 ± 0.31 vs 1.78 ± 0.45, P = 0.025; 0.39 ± 0.02 vs 0.57 ± 0.04, P = 0.003). Conclusion: ALHXW treatment can reverse CCl(4)-induced liver fibrosis in rats. Its mechanisms of anti-fibrosis may occur through the inhibition of TGF-β1 synthesis and TGF-β1/Smads signaling pathway, which in turn suppress the activation of hepatic stellate cells and thereby reverses fibrosis.

Follistatin on hepatic fibrotic rat liver PCNA, BrDU and activin A expression

Expression of Activins, Follistatin Mrna in the Development of Hepatic Fibrosis

Expression Changes of Activin A in the Process of Hepatic Fibrosis

Expression Changes of Activin A in the Development of Hepatic Fibrosis

EXPRESSION OF ACTIVIN SUBUNITS IN CCl4 INDUCED HEPATIC FIBROSIS IN RATS

Different Effects of Rat Interferon Alpha, Beta and Gamma on Rat Hepatic Stellate Cell Proliferation and Activation.

[Effects of Antisense Transforming Growth Factor Beta Receptor-Ii (tgfbetarii) Expressing Plasmid on Experimental Liver Fibrosis].

The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.

Attenuation Of Experimental Liver Fibrosis By Hepatocyte Growth Factor Gene Delivery Mediated By Adenovirus

Antagonizing Activin A/p15INK4b Signaling as Therapeutic Strategy for Liver Disease

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

Expression of Αvβ3 Integrin and Platelet-Endothelial Cell Adhesion Molecule-1 in Progressive Liver Fibrosis: Experiment with Rats

Blockage of Transforming Growth Factor Β Receptors Prevents Progression of Pig Serum-Induced Rat Liver Fibrosis

[Effect of Recombinant Human Augmenter of Liver Regeneration on Gene Expression of Tissue Inhibitor of Metalloproteinase-1 in Rat with Experimental Liver Fibrosis].

Raav2-Tgf-β(3) Decreases Collagen Synthesis and Deposition in the Liver of Experimental Hepatic Fibrosis Rat.

[Effects of Antisense Transforming Growth Factor Beta Receptor-I Expressing Plasmid on Pig Serum-Induced Rat Liver Fibrosis].

Inhibition of TGF1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy

Follistatin lowers blood pressure and improves vascular structure and function in essential and secondary hypertension

[Therapeutic Effects of Octreotide on Hepatofibrosis-Induced with Carbon Tetrachloride in Rats].

Inhibitory Effect of Human Interferon‐beta‐1a on Activated Rat and Human Hepatic Stellate Cells

[Effects of Anluohuaxianwan on Transforming Growth Factor-Β1 and Related Signaling Pathways in Rats with Carbon Tetrachloride-Induced Liver Fibrosis].